Antiplaque/antigingivitis OTC product combinations endorsed by Plaque Subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
ANTIPLAQUE/ANTIGINGIVITIS OTC COMBINATION POLICY ENDORSED by FDA's Dental Plaque Subcommittee at its meeting in Gaithersburg, Md. May 29. The subcommittee recommended that anticaries and tooth desensitizing agents appropriately could be combined with an approved antiplaque/antigingivitis ingredient or ingredient combination.